These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7322297)

  • 1. Discriminative stimulus properties of bremazocine in the rat.
    Shearman GT; Herz A
    Neuropharmacology; 1981 Dec; 20(12A):1209-13. PubMed ID: 7322297
    [No Abstract]   [Full Text] [Related]  

  • 2. Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists.
    Shearman GT; Herz A
    Psychopharmacology (Berl); 1982; 78(1):63-6. PubMed ID: 6292982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the discriminative stimulus properties of fentanyl and ethylketocyclazocine are mediated by an interaction with different opiate receptors.
    Shearman GT; Herz A
    J Pharmacol Exp Ther; 1982 Jun; 221(3):735-9. PubMed ID: 6283060
    [No Abstract]   [Full Text] [Related]  

  • 4. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-like discriminative stimulus properties of benzomorphans in the pigeon: stereospecificity and differential substitution patterns.
    Picker MJ; Negus SS; Dykstra LA
    Life Sci; 1989; 45(18):1637-45. PubMed ID: 2586224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethylketocyclazocine and bremazocine analgesia in neonatal rats.
    Helmstetter FJ; Calcagnetti DJ; Cramer CP; Fanselow MS
    Pharmacol Biochem Behav; 1988 Aug; 30(4):817-21. PubMed ID: 3067243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-choice drug discrimination in the rat: morphine, cyclazocine and saline.
    White JM; Holtzman SG
    J Pharmacol Exp Ther; 1981 May; 217(2):254-62. PubMed ID: 7229971
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroendocrine responses to benzomorphans (cyclazocine, ketocyclazocine and WIN 35, 197-2) in the rat.
    Murray GM; Kasson B; Garcia JA; George R
    Proc West Pharmacol Soc; 1978; 21():371-5. PubMed ID: 693519
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of the kappa-agonist bremazocine on ingestive behaviour in mice and rats.
    Hartig U; Opitz K
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):4-12. PubMed ID: 6307194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phencyclidine-like discriminative stimulus effects of the stereoisomers of alpha- and beta-cyclazocine in rats.
    Slifer BL; Balster RL
    J Pharmacol Exp Ther; 1988 Feb; 244(2):606-12. PubMed ID: 3346838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist.
    Fuller RW; Leander JD
    J Pharm Pharmacol; 1984 May; 36(5):345-6. PubMed ID: 6145778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vivo pharmacological analysis of benzomorphan binding sites in rats.
    Cowan A; Gmerek DE
    NIDA Res Monogr; 1984 Mar; 49():114-20. PubMed ID: 6090914
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat.
    Shearman GT; Herz A
    Eur J Pharmacol; 1982 Aug; 82(3-4):167-72. PubMed ID: 6290235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist and antagonist effects of prototype opiate drugs in fentanyl dose-dose discrimination.
    Colpaert FC; Janssen PA
    Psychopharmacology (Berl); 1986; 90(2):222-8. PubMed ID: 3097702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the delta opioid against BW373U86 in pigeons trained to discriminate fentanyl, bremazocine and water in a three-choice drug discrimination procedure.
    Negus SS; Morgan D; Cook CD; Picker MJ
    Psychopharmacology (Berl); 1996 Aug; 126(3):199-205. PubMed ID: 8876019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bremazocine: a potent, long-acting opiate kappa-agonist.
    Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
    Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
    [No Abstract]   [Full Text] [Related]  

  • 18. A correlative evaluation of cyclazocine, LSD and naloxone on continuous discriminated avoidance in rats.
    Wray SR
    Psychopharmacologia; 1972; 26(1):29-43. PubMed ID: 5051460
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of bremazocine on locomotor activity in DBA/2 and C57BL/6 mice.
    Castellano C; Pavone F
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):45-52. PubMed ID: 4096608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentazocine, cyclazocine, and nalorphine as discriminative stimuli.
    Hirschhorn ID
    Psychopharmacology (Berl); 1977 Nov; 54(3):289-94. PubMed ID: 413147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.